- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5585 - Eicosanoids, e.g. leukotrienes having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
Patent holdings for IPC class A61K 31/5585
Total number of patents in this class: 112
10-year publication summary
|
14
|
4
|
7
|
7
|
8
|
8
|
6
|
5
|
10
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| United Therapeutics Corporation | 290 |
13 |
| Toray Industries, Inc. | 6855 |
8 |
| Scipharm SARL | 29 |
6 |
| Camurus AB | 142 |
4 |
| Eli Lilly and Company | 3720 |
4 |
| Supernus Pharmaceuticals, Inc. | 132 |
4 |
| Pharmosa Biopharm Inc. | 16 |
4 |
| Cytoagents, Inc. | 13 |
4 |
| The Johns Hopkins University | 5533 |
3 |
| Teikoku Seiyaku Co., Ltd. | 186 |
3 |
| Topokine Therapeutics, Inc. | 30 |
3 |
| Vertex Pharmaceuticals Incorporated | 1568 |
2 |
| BeiGene, Ltd. | 349 |
2 |
| LTT Bio-Pharma Co., Ltd. | 46 |
2 |
| Lucolas-m.d. Ltd. | 5 |
2 |
| Endothel Pharma ApS | 2 |
2 |
| Celagenex Research (India) PVT. LTD. | 53 |
2 |
| Merck Sharp & Dohme Corp. | 2219 |
1 |
| Allergan, Inc. | 2438 |
1 |
| Bayer Schering Pharma AG | 429 |
1 |
| Other owners | 41 |